Incidental diagnosis of prostate cancer by F-18 FDG PET/CT

Clinical Nuclear Medicine

Volumn 35, Issue 1, 2010, Pages 34-35

  Monet, Antoine ^a   Merino, Bertrand ^a   Lupo, Régine ^b  

^a Centre d'Imagerie Fonctionnelle   (France)

^b Clinique Sainte Anne   (France)

Author keywords

FDG PET; Incidentally FDG uptake; Prostate cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROSTATE SPECIFIC ANTIGEN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CASE REPORT; CONTRAST ENHANCEMENT; DRUG EXCRETION; DRUG UPTAKE; HUMAN; INCIDENTAL FINDING; INJECTION; LARGE CELL LYMPHOMA; MALE; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; URINARY EXCRETION; WHOLE BODY CT; WHOLE BODY PET; ADENOCARCINOMA; AGED; COMPUTER ASSISTED TOMOGRAPHY; IMAGE SUBTRACTION; LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; LYMPHOMA; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75149136122     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181c361d6     Document Type: Article

References (9)

1. Ho L, Quan V, Henderson R, et al.. High-grade urothelial carcinoma of the prostate on FDG PET-CT. Clin Nucl Med. 2007;32:746-747. (Pubitemid 47294879)
2. Solis V, Rosenberg RJ, Spencer RP. B-cell lymphoma: a case with localized involvement of the prostate on F-18-FDG examination. Clin Nucl Med. 2005;30:236-237.
3. Liu Y. FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate. World J Surg Oncol. 2008;6:64.
4. Kao PF, Chou YH, Lai CW. Diffuse FDG uptake in acute prostatitis. Clin Nucl Med. 2008;33:308-310.
5. Jadvar H, Ye W, Groshen S, et al.. -F-18--fluorodeoxyglucose PET-CT of the normal prostate gland. Ann Nucl Med. 2008;22:787-793.
6. Gutman F, Aflalo-Hazan V, Kerrou K, et al.. 18F-choline PET/CT for initial staging of advanced prostate cancer. Am J Roentgenol. 2006;187:W618-W621.
7. Matthies A, Ezziddin S, Ulrich EM, et al.. Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT. Eur J Nucl Med Mol Imaging. 2004;31:797.
8. Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med. 2006;36:51-72.
9. Oyama N, Akino H, Suzuki Y, et al.. Prognostic value of 2-deoxy-2- -F-18-fluoro-D-glucose positron emission tomography imaging for patients with prostate cancer. Mol Imaging Biol. 2002;4:99-104.